Taking ovarian cancer diagnosis to the next level: differential diagnosis of malignancy type, and added value of advanced data sources such as MRI, proteomics, circulating tumour DNA and circulating tumour cells KU Leuven
Excellent tools to predict whether a detected ovarian tumour is benign or malignant prior to surgery are pivotal for several reasons: (1) currently a minority of ovarian cancers is treated by experienced gynaecological oncologists, (2) the value of screening for ovarian cancer has not been established, and (3) ovarian cancer is largely asymptomatic in its early stages such that accurate diagnosis is paramount to optimize survival. The ...